Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis - A Prospective, Randomized, and Double-Blind Clinical Study Using a Two-by-Two Factorial Design

NCT00619203 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.

NCT NCT00619203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis - A Prospective, Randomized, and Double-Blind Clinical Study Using a Two-by-Two Factorial Design
Lead sponsor
Kamuzu University of Health Sciences
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
March 31, 2012
Enrollment
466 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial meningitis